The assessment of vision has a growing importance in the management of retinoblastoma in the era of globe-conserving therapy, both prior to and after treatment. As survival rates approach 98-99% and globe salvage rates reach ever-higher levels, it is important to provide families with information regarding the visual outcomes of different treatments. We present an overview of the role of vision in determining the treatment given and the impact of complications of treatment. We also discuss screening and treatment strategies that can be used to maximise vision.
摘要: 在全球保守治疗视网膜母细胞瘤的时代中, 治疗前后的视力评估在视网膜母细胞瘤的管理中日益重要。随着生存率接近98-99%, 全球挽救率达更高水平, 向家庭提供不同治疗方法的视力结局的信息非常重要。我们概述了视力在决定治疗方式和治疗并发症的影响中的作用。我们还讨论了筛查和治疗策略, 以最大限度地提高视力。.
© 2021. The Author(s).